590 kr
Research-grade peptide material supplied as lyophilized powder. Produced under controlled conditions and supported by batch-specific analytical documentation.
For Research Use Only. Not for human or veterinary use.
590 kr
Research-grade peptide material supplied as lyophilized powder. Produced under controlled conditions and supported by batch-specific analytical documentation.
For Research Use Only. Not for human or veterinary use.
CJC-1295 with DAC is a synthetic long-acting growth hormone-releasing hormone (GHRH) analogue supplied for laboratory research use only.
Published scientific literature has investigated CJC-1295 with DAC in relation to GHRH receptor biology, peptide-albumin conjugation and endocrine signaling research models.
Each batch is linked to a batch-specific Certificate of Analysis (COA).
Available documentation may include purity testing, identity verification, and batch-related analytical data.
Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, et al.
Human growth hormone-releasing factor (hGRF)1–29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.
Endocrinology. 2005;146(7):3052–3058.
PMID: 15817669
DOI: 10.1210/en.2004-1286
Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA.
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799–805.
PMID: 16352683
DOI: 10.1210/jc.2005-1536
Ionescu M, Frohman LA.
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.
Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4792–4797.
PMID: 17018654
DOI: 10.1210/jc.2006-1702
Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R.
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.
American Journal of Physiology-Endocrinology and Metabolism. 2006;291(6):E1290–E1294.
PMID: 16822960
DOI: 10.1152/ajpendo.00201.2006
This product is supplied strictly for laboratory research purposes.
It is not intended for human use, veterinary use, diagnostic applications, or therapeutic and clinical applications.
True Peptides does not provide dosing guidance, administration instructions, or usage recommendations.
Product Name: 10-Amino-1MQ 50 mg
LOT Number: 240710A
Expiration Date: July 18, 2028
Storage Conditions: 2–8 °C, unless otherwise specified
Use Category: Research Use Only
This batch is linked to analytical documentation intended to support traceability and laboratory recordkeeping.
The COA may include:
• batch identification
• analytical purity results
• identity verification
• method reference information
This page applies only to the lot number listed above.
Documentation shown here is batch-specific and should not be used as a reference for other lots or product versions.
This material is supplied strictly for laboratory research purposes.
It is not intended for:
• human use
• veterinary use
• diagnostic applications
• therapeutic or clinical applications
True Peptides does not provide dosing guidance, administration instructions, or usage recommendations.
All analytical data provided is batch-specific and linked to the corresponding product.
Transparency in documentation allows for:
True Peptides prioritizes accessible and verifiable documentation as a core part of its quality framework.
Peptide materials are supplied as lyophilized powders.
Recommended storage: 2–8°C refrigerated, unless otherwise specified.
Proper storage conditions are required to maintain material integrity. Stability may vary depending on peptide structure and environmental exposure.
Handling should be performed within controlled laboratory conditions.
